This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Trials in Progress
Trials in Progress
ARAMON Trial
ARASEC Trial
ARASTEP Trial
ECLIPSE Trial
Oral EPI-7386
SPLASH Trial
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Suprapubic Catheter
Diane K. Newman, DNP FAAN BCB-PMD
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASCO 2023
AUA 2023
ASCO GU 2023
EAU 2023
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Conferences
Recent Abstracts
AUA 2023: What is the "Best" Diversion: Conduit or Neobladder?
May 1, 2023
AUA 2023: Optimal TURBT: Do Skilled Urologists Really Need PDD?
May 1, 2023
AUA 2023: Pathology or 'Markers': What is More Important?
May 1, 2023
AUA 2023: Updated Progression-Free Survival from PRESTO: a Phase 3 Randomized Study of Androgen Annihilation for High-Risk Biochemically Relapsed Prostate Cancer (AFT-19)
May 1, 2023
AUA 2023: Results From the Extended Follow-up in Patients With Muscle-Invasive Bladder Cancer in the Checkmate 274 Trial
May 1, 2023
AUA 2023: Artificial Intelligence-Enabled Automated Identification of Key Steps in Robotic-Assisted Radical Prostatectomy
May 1, 2023
AUA 2023: Role of Adjuvant Immunotherapy for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection
May 1, 2023
AUA 2023: A Single Centre Prospective Randomized Controlled Study to Assess Outcomes and Complications of Conventional Stent Placement Versus No Stent Placement after Ureteroscopy for Distal Ureteric Calculus of Size 1 cms
May 1, 2023
AUA 2023: Optimal Management of cN+ Muscle Invasive Bladder Cancer
May 1, 2023
AUA 2023: Intermediate Risk NMIBC: Surveillance and Treatment Challenges
May 1, 2023
AUA 2023: Perioperative Outcomes of Radical Cystectomy Following Neoadjuvant Gemcitabine, Cisplatin and Atezolizumab
May 1, 2023
AUA 2023: Second Update: Is Combination Therapy the New Standard of Care for Metastatic Castrate Resistant Prostate Cancer Patients?
May 1, 2023
AUA 2023: Prostate Cancer Guidelines — Where I See Progress and Help with My Practice
May 1, 2023
AUA 2023: First Update: Managing our Metastatic Hormone Sensitive Prostate Cancer Patients: Are We There Yet?
May 1, 2023
AUA 2023: The Effects of Sequential Mitomycin and BCG Treatment Versus BCG Monotherapy in Patients With High-risk Non-muscle Invasive Bladder Cancer: MITO-BCG
April 30, 2023
AUA 2023: First Results from SunRISe-1 in Patients with BCG Unresponsive High-Risk Non–muscle-Invasive Bladder Cancer Receiving TAR-200 in Combination With Cetrelimab, TAR-200, or Cetrelimab Alone
April 30, 2023
AUA 2023: Biochemical Recurrence of Localized Prostate Cancer Originating From the Transition Versus Peripheral Zone: a Systematic Review and Meta-Analysis
April 30, 2023
AUA 2023: New Guidelines for Sexual Health Care with Prostate Cancer
April 30, 2023
AUA 2023: Debate: Renaming Gleason 6 Prostate Cancer
April 30, 2023
AUA 2023: Associations Between Prostate MRI and Genomic Testing and Treatment Intensification Among Patients with Localized Prostate Cancer
April 30, 2023
Page 11 of 522
Start
Prev
6
7
8
9
10
11
12
13
14
15
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free